Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines
10 May 2021 | 09:36 am |
Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.
The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope.
Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:
"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.
"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Arch Re on cross-border insurance business transfer
Multinational law firm Pinsent Masons has advised two subsidiaries of Arch Re – Southern Rock Insurance Company Limited (Southern Rock) and Alwyn Insurance Company Limited (Alwyn) – on the successful completion of an insurance business transfer under Part VII of the Financial Services and Markets Act 2000.
Pinsent Masons advises on acquisition of Alba Renewables
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
Pinsent Masons advises Aviva on Part VII transfer of former AIG Life protection business
Multinational law firm Pinsent Masons has advised the Aviva Group on the successful High Court-sanctioned transfer of the entire insurance business of Aviva Protection UK Limited (formerly AIG Life) to Aviva Life & Pensions UK Limited, under a Part VII insurance business transfer scheme.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons announces FY24/25 results
Multinational law firm Pinsent Masons has today unveiled its unaudited financial results for the year ending 30 April 2025. This year's results have delivered a revenue increase of 4.7% after a year of continued growth within the firm’s core sectors and across its jurisdictions.
Pinsent Masons announces new leadership for Global IP Group and Life Sciences
Pinsent Masons has appointed Judith Krens (Partner, Amsterdam) and Tom Nener (Partner, Birmingham) as co-leads of the Global Intellectual Property (IP) team, and has appointed Charlotte Weekes (Partner, London) as Head of Life Sciences. The appointments come in light of the upcoming departure of Clare Tunstall, the current Head of IP and Life Sciences, who will be leaving the firm in the Autumn.
Pinsent Masons hires senior litigation and investigations partner Melanie Ryan in London
Multinational law firm Pinsent Masons has appointed litigation partner Melanie Ryan to join its Global Investigations team in London.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]